Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants.

Preterm infants are highly susceptible to life-threatening infections that are clinically difficult to detect, such as late-onset septicemia and necrotizing enterocolitis (NEC). Here, we used a proteomic approach to identify biomarkers for diagnosis of these devastating conditions. In a case-control study comprising 77 sepsis/NEC and 77 nonsepsis cases (10 in each group being monitored longitudinally), plasma samples collected at clinical presentation were assessed in the biomarker discovery and independent validation phases. We validated the discovered biomarkers in a prospective cohort study with 104 consecutively suspected sepsis/NEC episodes. Proapolipoprotein CII (Pro-apoC2) and a des-arginine variant of serum amyloid A (SAA) were identified as the most promising biomarkers. The ApoSAA score computed from plasma apoC2 and SAA concentrations was effective in identifying sepsis/NEC cases in the case-control and cohort studies. Stratification of infants into different risk categories by the ApoSAA score enabled neonatologists to withhold treatment in 45% and enact early stoppage of antibiotics in 16% of nonsepsis infants. The negative predictive value of this antibiotic policy was 100%. The ApoSAA score could potentially allow early and accurate diagnosis of sepsis/NEC. Upon confirmation by further multicenter trials, the score would facilitate rational prescription of antibiotics and target infants who require urgent treatment.

[1]  S. Ngai,et al.  A magnetic bead‐based serum proteomic fingerprinting method for parallel analytical analysis and micropreparative purification , 2010, Electrophoresis.

[2]  M. Hacımustafaoğlu,et al.  Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants , 2009, Journal of Perinatology.

[3]  B. Schmidt,et al.  Using a Count of Neonatal Morbidities to Predict Poor Outcome in Extremely Low Birth Weight Infants: Added Role of Neonatal Infection , 2009, Pediatrics.

[4]  B. Stoll,et al.  Prolonged Duration of Initial Empirical Antibiotic Treatment Is Associated With Increased Rates of Necrotizing Enterocolitis and Death for Extremely Low Birth Weight Infants , 2009, Pediatrics.

[5]  B. Stoll,et al.  Very Low Birth Weight Preterm Infants With Surgical Short Bowel Syndrome: Incidence, Morbidity and Mortality, and Growth Outcomes at 18 to 22 Months , 2008, Pediatrics.

[6]  B. Stoll,et al.  Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. , 2008, Seminars in perinatology.

[7]  T. Fok,et al.  High-Dose Oral Erythromycin Decreased the Incidence of Parenteral Nutrition-Associated Cholestasis in Preterm Infants , 2007, Gastroenterology.

[8]  R. Regev,et al.  Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis , 2007, Journal of Perinatology.

[9]  Terence C W Poon,et al.  Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices , 2007, Expert review of proteomics.

[10]  V. Bhandari,et al.  Proteomic Profiling of the Amniotic Fluid to Detect Inflammation, Infection, and Neonatal Sepsis , 2007, PLoS medicine.

[11]  D. Ward,et al.  Preclinical and post-treatment changes in the HCC-associated serum proteome , 2006, British Journal of Cancer.

[12]  B. Stoll,et al.  Neonatal infection and long-term neurodevelopmental outcome in the preterm infant , 2006, Current opinion in infectious diseases.

[13]  Geng Li,et al.  Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. , 2006, Clinical chemistry.

[14]  P. Ng,et al.  Diagnostic markers for neonatal sepsis , 2006, Current opinion in pediatrics.

[15]  J. Sung,et al.  Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome , 2006, Clinical chemistry.

[16]  Geng Li,et al.  Quantitative Measurement of Monocyte HLA-DR Expression in the Identification of Early-Onset Neonatal Infection , 2006, Neonatology.

[17]  Henrik Zetterberg,et al.  Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. , 2005, Journal of proteome research.

[18]  Nathalie Wong,et al.  Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. , 2005, Clinical chemistry.

[19]  Sofia Bauer,et al.  Serum Amyloid A Protein Is a Useful Inflammatory Marker during Late-Onset Sepsis in Preterm Infants , 2005, Neonatology.

[20]  B. Vohr,et al.  Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. , 2004, JAMA.

[21]  Geng Li,et al.  Neutrophil CD64 Is a Sensitive Diagnostic Marker for Early-Onset Neonatal Infection , 2004, Pediatric Research.

[22]  Kenneth R Feingold,et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.

[23]  T. Fok,et al.  Combined use of alcohol hand rub and gloves reduces the incidence of late onset infection in very low birthweight infants , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[24]  P. Ng,et al.  Diagnostic markers of infection in neonates , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[25]  E. Diamandis.  Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. , 2004, Journal of the National Cancer Institute.

[26]  T. Fishbein,et al.  Parenteral nutrition associated liver disease. , 2003, Seminars in neonatology : SN.

[27]  J. Verhoef,et al.  Lipoprotein metabolism in patients with severe sepsis , 2003, Critical care medicine.

[28]  R. Ye,et al.  Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. , 2003, Blood.

[29]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[30]  T. Fok,et al.  Neutrophil CD64 Expression: A Sensitive Diagnostic Marker for Late-Onset Nosocomial Infection in Very Low Birthweight Infants , 2002, Pediatric Research.

[31]  K. Lackner,et al.  ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. , 2001, Journal of lipid research.

[32]  L. Havekes,et al.  Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[33]  T F Fok,et al.  Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[34]  R. Badolato,et al.  Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.

[35]  I. Goldberg,et al.  Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. , 1990, The Journal of biological chemistry.

[36]  C. Maury,et al.  Comparative study of serum amyloid A protein and C-reactive protein in disease. , 1985, Clinical science.

[37]  M. Taskinen,et al.  Postheparin Plasma Lipoprotein and Hepatic Lipases in Preterm Neonates , 1984, Pediatric Research.

[38]  C. Shelley,et al.  Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance. , 1984, Nucleic acids research.

[39]  T. Fok,et al.  IP-10 Is an Early Diagnostic Marker for Identification of Late-Onset Bacterial Infection in Preterm Infants , 2007, Pediatric Research.

[40]  I. Goldberg,et al.  Lipoprotein ApoC-II Activation of Lipoprotein Lipase , 1990 .

[41]  A. Fanaroff,et al.  Necrotizing enterocolitis: a practitioner's perspective. , 1988, Pediatrics in review.

[42]  C. Alvarez,et al.  Lipids, lipoproteins, and apoproteins in serum during infection. , 1986, Clinical chemistry.